Filing Details
- Accession Number:
- 0001576427-17-000168
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-08-16 16:06:33
- Reporting Period:
- 2017-08-15
- Filing Date:
- 2017-08-16
- Accepted Time:
- 2017-08-16 16:06:33
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1576427 | Criteo S.a. | CRTO | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1193080 | James Warner | C/O Criteo Legal Dept. 387 Park Avenue South, 12Th Floor New York NY 10016 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Acquisiton | 2017-08-15 | 1,250 | $0.83 | 1,250 | No | 4 | M | Direct | |
Ordinary Shares | Disposition | 2017-08-15 | 1,250 | $51.49 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Ordinary Shares | Non-employee Warrant (right to buy) | Disposition | 2017-08-15 | 1,250 | $0.00 | 1,250 | $0.83 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
9,750 | 2020-11-16 | No | 4 | M | Direct |
Footnotes
- The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- The exercise price of the warrant is 0.70 euros. The U.S. dollar equivalent of the exercise price is $0.83 using the Federal Reserve Bank of New York noon buying rate for August 11, 2017 (1.00 = $1.1811).
- For more information about the equity of the issuer held by the reporting person, please see the issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission.
- The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan (the "Trading Plan") adopted by the reporting person. The sales are made in accordance with a trading schedule that is established at the time the Trading Plan is put in place. The reporting person entered into the Trading Plan during an open trading window of the issuer pursuant to its Insider Trading Policy.
- Warrant granted on November 16, 2010. One-fourth of the grant vested on the first anniversary of the grant date and an additional 1/16th of the grant vests quarterly thereafter.